<html>

<head>


<title>Mentor Receives Binding Offer from Coloplast</title>



</head>

<body lang=EN-US style='text-justify-trim:punctuation'>



<div style='border:none;border-top:double windowtext 6.75pt;padding:0in 0in 0in 0in'>

<p style='border:none;padding:0in'>&nbsp;</p>

</div>

<p align=center style='text-align:center'><b><font face="Arial" size="4">UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
</font>
</b><font face="Arial">Washington, DC 20549</font></p>



<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="25%" noshade color=black align=center>

</div>



<p align=center style='text-align:center'><font face="Arial" size="4"><b>FORM 8&#8209;K</b></font></p>



<p align=center style='text-align:center'><font face="Arial" size="2">CURRENT REPORT<br>
Pursuant to Section 13 or 15(d) of<br>
the Securities Exchange Act of 1934</font></p>

<p align=center style='text-align:center'><font face="Arial" size="2">Date of Report
(Date of earliest event reported)<br>
</font><font face="Arial" size="4">
<b>March 27, 2006</b></font></p>



<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="25%" noshade color=black align=center>

</div>



<p align=center style='text-align:center'><font face="Arial" size="4"><b>MENTOR
CORPORATION<br>
</b></font><font face="Arial" size="2">(Exact
name of registrant as specified in its charter)</font></p>



<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse'>
 <tr>
  <td width="29%" valign=top style='width:29.44%;padding:0in .7pt 0in .7pt'>
  <p align=center style='text-align:center'><font face="Arial" size="2"><b><u>Minnesota</u></b></font></p>
  </td>
  <td width="3%" valign=bottom style='width:3.74%;padding:0in .7pt 0in .7pt'>
  <p><font face="Arial" size="2"><b>&nbsp;</b></font></p>
  </td>
  <td width="31%" valign=top style='width:31.78%;padding:0in .7pt 0in .7pt'>
  <p align=center style='text-align:center'><font face="Arial" size="2"><b><u>0-7955</u></b></font></p>
  </td>
  <td width="2%" valign=bottom style='width:2.5%;padding:0in .7pt 0in .7pt'>
  <p><font face="Arial" size="2"><b>&nbsp;</b></font></p>
  </td>
  <td width="32%" valign=top style='width:32.54%;padding:0in .7pt 0in .7pt'>
  <p align=center style='text-align:center'><font face="Arial" size="2"><b><u>41-0950791</u></b></font></p>
  </td>
 </tr>
 <tr>
  <td width="29%" valign=top style='width:29.44%;padding:0in .7pt 0in .7pt'>
  <p align=center style='text-align:center'><font face="Arial" size="2">(State or
  other jurisdiction of
  incorporation)</font></p>
  </td>
  <td width="3%" valign=bottom style='width:3.74%;padding:0in .7pt 0in .7pt'>

  </td>
  <td width="31%" valign=top style='width:31.78%;padding:0in .7pt 0in .7pt'>
  <p align=center style='text-align:center'><font face="Arial" size="2">(Commission
  File Number)</font></p>
  </td>
  <td width="2%" valign=bottom style='width:2.5%;padding:0in .7pt 0in .7pt'>

  </td>
  <td width="32%" valign=top style='width:32.56%;padding:0in .7pt 0in .7pt'>
  <p align=center style='text-align:center'><font face="Arial" size="2">(IRS Employer<br>
  Identification No.)</font></p>
  </td>
 </tr>
</table>

</div>





<p align=center style='text-align:center'><font face="Arial" size="2"><b>201 Mentor Drive<br>
Santa Barbara, California&nbsp; 93111<br>
</b>(Address of
principal executive offices, including zip code)</font></p>



<p align=center style='text-align:center'><font face="Arial" size="2"><b>(805) 879-6000<br>
</b>(Registrant's
telephone number, including area code)</font></p>





<p><font face="Arial" size="2">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (SEE General Instruction A.2. below):</font></p>



<p><font face="Arial" size="2">[&nbsp; ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)</font></p>



<p><font face="Arial" size="2">[&nbsp; ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>



<p><font face="Arial" size="2">[&nbsp; ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))</font></p>



<p><font face="Arial" size="2">[&nbsp; ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))</font></p>
<p>&nbsp;</p>
<p>&nbsp;</p>





<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" noshade color=navy align=center>

</div>



<font face="Arial" size="2">



<br clear=all
style='page-break-before:always'>










</font>










<p><font face="Arial" size="2"><b>Item
1.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Entry into a Material Definitive Agreement.</b></font></p>



<p><font face="Arial" size="2">On March 27, 2006, Mentor Corporation (&quot;Mentor&quot;) received a binding offer
(the &quot;Offer&quot;) from Coloplast A/S (&quot;Coloplast&quot;) to purchase Mentor's surgical
urology and clinical and consumer healthcare business segments (collectively,
the &quot;Urology Business&quot;) for total consideration of $463,225,000, of which
$456,137,500 would be in cash and $7,087,500 in non-cash consideration (the
&quot;Transaction&quot;).&nbsp; The Offer is binding on Coloplast and
capable of being accepted by Mentor until 11:59 p.m., California time, on July
31, 2006.</font></p>



<p><font face="Arial" size="2">If Mentor accepts the Offer, the parties would execute a
definitive purchase agreement relating to the Transaction.&nbsp; The definitive
purchase agreement as proposed by Coloplast would contain customary representations and warranties,
covenants by Mentor regarding the operation of its business between the date of
signing of any such definitive purchase agreement and the date of the closing
of the Transaction, and indemnification provisions whereby each party would
agree to indemnify the other for breaches of representations and warranties,
breaches of covenants and other matters, with Mentor's liability for breaches
of representations and warranties generally limited to 15% of the purchase
price.&nbsp; The definitive purchase agreement
as proposed by Coloplast would also
provide for the establishment of an escrow fund of $10 million, to be withheld
from the purchase price, to secure Mentor's indemnification obligations with
respect to breaches of its representations and warranties.&nbsp; In addition, Mentor
would agree not to enter into or engage in a business that competes with the
Urology Business, on a worldwide basis, for a period of seven years following
the closing of the Transaction.&nbsp; The Transaction proposed
by Coloplast would be subject to
customary closing conditions, including the receipt of required regulatory
approvals and the receipt of the considered advice from French Works Councils.</font></p>



<p><font face="Arial" size="2">In consideration of the Offer, Mentor has agreed that during the irrevocable
period of the Offer, Mentor will
not solicit any proposal or offer from, or enter into any discussions or
negotiations with, any third party regarding any acquisition of the Urology
Business or any material portion of the assets of the Urology Business.</font></p>

<p><font face="Arial" size="2"><b>Item 8.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Events.</b></font></p>

<p><font face="Arial" size="2">On March 27, 2006, Mentor issued a press release
relating to its receipt of the Offer from Coloplast.&nbsp; The text of the press
release is attached hereto as Exhibit 99.1 and is incorporated in its entirety
herein by reference. </font></p>

<p><font face="Arial" size="2"><b>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Statements and
Exhibits.</b></font></p>



<p><font face="Arial" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibits.</font></p>



<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:77.4pt;border-collapse:collapse'>
 <tr>
  <td width=104 valign=top style='width:78.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p style='margin-bottom:12.0pt'><font face="Arial" size="2"><b><u>Exhibit No.</u></b></font></p>
  </td>
  <td width=430 valign=top style='width:322.5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p style='margin-bottom:12.0pt'><font face="Arial" size="2"><b><u>Exhibit Title or Description</u></b></font></p>
  </td>
 </tr>
 <tr>
  <td width=104 valign=top style='width:78.0pt;padding:0in 5.4pt 0in 5.4pt'>
  &nbsp;</td>
  <td width=430 valign=top style='width:322.5pt;padding:0in 5.4pt 0in 5.4pt'>
  &nbsp;</td>
 </tr>
 <tr>
  <td width=104 valign=top style='width:78.0pt;padding:0in 5.4pt 0in 5.4pt'>
  <p style='margin-bottom:12.0pt'><font face="Arial" size="2">99.1</font></p>
  </td>
  <td width=430 valign=top style='width:322.5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p style='margin-bottom:12.0pt'><font face="Arial" size="2">Press Release Issued by Mentor Corporation,
  dated March 27, 2006</font></p>
  </td>
 </tr>
</table>





<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>





<div>

<table cellspacing=0 cellpadding=0 hspace=0 vspace=0 align=center>
 <tr>
  <td valign=top align=left style='padding-top:0in;padding-right:0in;
  padding-bottom:0in;padding-left:0in'>
  <p><font face="Arial" size="2">2</font></p>
  </td>
 </tr>
</table>

</div>

<font face="Arial" size="2">

<br clear=ALL>



</font>



<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" noshade color=navy align=center>

</div>



<font face="Arial" size="2">



<br clear=all
style='page-break-before:always'>












</font>












<p align=center style='text-align:center'><font face="Arial" size="2"><b>SIGNATURE</b></font></p>



<p><font face="Arial" size="2">Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</font></p>





<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='width:59%;border-collapse:collapse'>
 <tr style='height:12.95pt'>
  <td valign=bottom style='width:37%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:11%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2"><b>&nbsp;</b></font></p>
  </td>
  <td valign=bottom style='width:44%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2"><b>Mentor Corporation</b></font></p>
  </td>
 </tr>
 <tr style='height:12.95pt'>
  <td valign=bottom style='width:37%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:11%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:44%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
 </tr>
 <tr style='height:12.95pt'>
  <td valign=bottom style='width:37%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2">Date:&nbsp;
  March 31, 2006</font></p>
  </td>
  <td valign=bottom style='width:11%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p align=right style='text-align:right'><font face="Arial" size="2">By:</font></p>
  </td>
  <td valign=bottom style='border-left:medium none; border-right:medium none; border-top:medium none; width:44%;border-bottom:
  1.0pt solid windowtext;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2">/s/Joshua
  H. Levine</font></p>
  </td>
 </tr>
 <tr style='height:12.95pt'>
  <td valign=bottom style='width:37%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:11%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:44%;border:medium none;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2">Joshua H.
  Levine</font></p>
  </td>
 </tr>
 <tr style='height:12.95pt'>
  <td valign=bottom style='width:37%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:11%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:44%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2">Chief
  Executive Officer</font></p>
  </td>
 </tr>
 <tr style='height:12.95pt'>
  <td valign=bottom style='width:37%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:11%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:44%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
 </tr>
 <tr style='height:12.95pt'>
  <td valign=bottom style='width:37%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2">Date:&nbsp;
  March 31, 2006</font></p>
  </td>
  <td valign=bottom style='width:11%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p align=right style='text-align:right'><font face="Arial" size="2">By:&nbsp;
	</font> </p>
  </td>
  <td valign=bottom style='border-left:medium none; border-right:medium none; border-top:medium none; width:44%;border-bottom:
  1.0pt solid windowtext;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2">/s/Loren
  L. McFarland</font></p>
  </td>
 </tr>
 <tr style='height:12.95pt'>
  <td valign=bottom style='width:37%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:11%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:44%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2">Loren L.
  McFarland</font></p>
  </td>
 </tr>
 <tr style='height:12.95pt'>
  <td valign=bottom style='width:37%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:11%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>

  </td>
  <td valign=bottom style='width:44%;height:12.95pt; padding-left:.7pt; padding-right:.7pt; padding-top:0in; padding-bottom:0in'>
  <p><font face="Arial" size="2">Chief
  Financial Officer</font></p>
  </td>
 </tr>
</table>





<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>





<div>

<table cellspacing=0 cellpadding=0 hspace=0 vspace=0 align=center>
 <tr>
  <td valign=top align=left style='padding-top:0in;padding-right:0in;
  padding-bottom:0in;padding-left:0in'>
  <p><font face="Arial" size="2">3</font></p>
  </td>
 </tr>
</table>

</div>

<font face="Arial" size="2">

<br clear=ALL>



</font>



<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" noshade color=navy align=center>

</div>



<font face="Arial" size="2">



<br clear=all
style='page-break-before:always'>










</font>










<p align=center style='text-align:center'><font face="Arial" size="2"><b>Exhibit Index</b></font></p>
<p align=center style='text-align:center'>&nbsp;</p>





<div align="center">





<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse'>
 <tr>
  <td width=97 valign=top style='width:72.8pt;padding:0in 5.4pt 0in 5.4pt'>
  <p style='margin-bottom:12.0pt'><font face="Arial" size="2"><b><u>Exhibit No.</u></b></font></p>
  </td>
  <td width=479 valign=top style='width:359.4pt;padding:0in 5.4pt 0in 5.4pt'>
  <p style='margin-bottom:12.0pt'><font face="Arial" size="2"><b><u>Exhibit Title or Description</u></b></font></p>
  </td>
 </tr>
 <tr>
  <td width=97 valign=top style='width:72.8pt;padding:0in 5.4pt 0in 5.4pt'>
  &nbsp;</td>
  <td width=479 valign=top style='width:359.4pt;padding:0in 5.4pt 0in 5.4pt'>
  &nbsp;</td>
 </tr>
 <tr>
  <td width=97 valign=top style='width:72.8pt;padding:0in 5.4pt 0in 5.4pt'>
  <p style='margin-bottom:12.0pt'><font face="Arial" size="2">99.1</font></p>
  </td>
  <td width=479 valign=top style='width:359.4pt;padding:0in 5.4pt 0in 5.4pt'>
  <p style='margin-bottom:12.0pt'><font face="Arial" size="2">Press Release Issued by Mentor Corporation,
  dated March 27, 2006</font></p>
  </td>
 </tr>
</table>

</div>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>
<p style="margin-bottom: 12.0pt">&nbsp;</p>

<div>

<table cellspacing=0 cellpadding=0 hspace=0 vspace=0 align=center>
 <tr>
  <td valign=top align=left style='padding-top:0in;padding-right:0in;
  padding-bottom:0in;padding-left:0in'>
  <p><font face="Arial" size="2">4</font></p>
  </td>
 </tr>
</table>

</div>

<font face="Arial" size="2">

<br clear=ALL>



</font>



<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" noshade color=navy align=center>

</div>







</body>

</html>
[{"type": "8-K", "sequence": "1", "filename": "k8mar3106.htm", "description": "8-K - MENTOR RECEIVES BINDING OFFER FROM COLOPLAST", "secsgml_size_bytes": 19154}]
{"company-data": {"conformed-name": "MENTOR CORP /MN/", "cik": "0000064892", "assigned-sic": "3842", "irs-number": "410950791", "state-of-incorporation": "MN", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-31744", "film-number": "06730347"}, "business-address": {"street1": "201 MENTOR DR", "city": "SANTA BARBARA", "state": "CA", "zip": "93111", "phone": "8058796000"}, "mail-address": {"street1": "201 MENTOR DR", "city": "SANTA BARBARA", "state": "CA", "zip": "93111"}}
Mentor Receives Binding Offer from Coloplast
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8‑K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported)
March 27, 2006
MENTOR
CORPORATION
(Exact
name of registrant as specified in its charter)
Minnesota
0-7955
41-0950791
(State or
  other jurisdiction of
  incorporation)
(Commission
  File Number)
(IRS Employer
Identification No.)
201 Mentor Drive
Santa Barbara, California  93111
(Address of
principal executive offices, including zip code)
(805) 879-6000
(Registrant's
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (SEE General Instruction A.2. below):
[  ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[  ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[  ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item
1.01          Entry into a Material Definitive Agreement.
On March 27, 2006, Mentor Corporation ("Mentor") received a binding offer
(the "Offer") from Coloplast A/S ("Coloplast") to purchase Mentor's surgical
urology and clinical and consumer healthcare business segments (collectively,
the "Urology Business") for total consideration of $463,225,000, of which
$456,137,500 would be in cash and $7,087,500 in non-cash consideration (the
"Transaction").  The Offer is binding on Coloplast and
capable of being accepted by Mentor until 11:59 p.m., California time, on July
31, 2006.
If Mentor accepts the Offer, the parties would execute a
definitive purchase agreement relating to the Transaction.  The definitive
purchase agreement as proposed by Coloplast would contain customary representations and warranties,
covenants by Mentor regarding the operation of its business between the date of
signing of any such definitive purchase agreement and the date of the closing
of the Transaction, and indemnification provisions whereby each party would
agree to indemnify the other for breaches of representations and warranties,
breaches of covenants and other matters, with Mentor's liability for breaches
of representations and warranties generally limited to 15% of the purchase
price.  The definitive purchase agreement
as proposed by Coloplast would also
provide for the establishment of an escrow fund of $10 million, to be withheld
from the purchase price, to secure Mentor's indemnification obligations with
respect to breaches of its representations and warranties.  In addition, Mentor
would agree not to enter into or engage in a business that competes with the
Urology Business, on a worldwide basis, for a period of seven years following
the closing of the Transaction.  The Transaction proposed
by Coloplast would be subject to
customary closing conditions, including the receipt of required regulatory
approvals and the receipt of the considered advice from French Works Councils.
In consideration of the Offer, Mentor has agreed that during the irrevocable
period of the Offer, Mentor will
not solicit any proposal or offer from, or enter into any discussions or
negotiations with, any third party regarding any acquisition of the Urology
Business or any material portion of the assets of the Urology Business.
Item 8.01          Other Events.
On March 27, 2006, Mentor issued a press release
relating to its receipt of the Offer from Coloplast.  The text of the press
release is attached hereto as Exhibit 99.1 and is incorporated in its entirety
herein by reference.
Item 9.01          Financial Statements and
Exhibits.
(d)         Exhibits.
Exhibit No.
Exhibit Title or Description
99.1
Press Release Issued by Mentor Corporation,
  dated March 27, 2006
2
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Mentor Corporation
Date: 
  March 31, 2006
By:
/s/Joshua
  H. Levine
Joshua H.
  Levine
Chief
  Executive Officer
Date: 
  March 31, 2006
By:
/s/Loren
  L. McFarland
Loren L.
  McFarland
Chief
  Financial Officer
3
Exhibit Index
Exhibit No.
Exhibit Title or Description
99.1
Press Release Issued by Mentor Corporation,
  dated March 27, 2006
4